A delay or failure in the healing of a bone fracture site is a very common and critical problem, requiring proper medical intervention. Such nonunions, which occur in nearly 5% of fracture cases every year across the world, develop for a variety of reasons, such as infection, large fracture gaps, imperfectly aligned ends of fracture, and insufficient immobilization. In cases like these, bone growth stimulators are as a supplemental form of treatment to help improve the healing rate of fractures. Bone growth stimulators are devices that provide low-level pulses of electromagnetic energy to the fracture site, stimulating the natural healing process of bones. Over the years, bone growth stimulators have become an efficient fracture healing modality and their use has become common in the field of orthopedics.
In 2014, the global bone growth stimulators market was pegged at US$ 922.2 mn in a market research report published by Future Market Insights (FMI). The market held a massive 20% of the global orthobiologics market. The report states that the market will exhibit a healthy 9.5% CAGR from 2015 through 2025 and will rise to US$2,502.0 mn by 2025. Innovation in product designs, technological advancements, an expanding set of applications in the sports medicine sector, and rising healthcare expenditure are among the major factors fueling the overall demand for a variety of bone growth stimulators globally.
Less Complex Non-invasive Devices Lead Despite Less Patient Compliance
There are three most popular varieties of bone growth stimulation devices that are available in the market presently – internal/invasive, external/non-invasive, and ultrasound bone growth stimulators.
The segment of internal bone growth stimulators includes devices that are implanted on the fusion site, delivering electrical energy directly to the ends of a fracture. Internal bone growth stimulators can remain at the fracture site for durations as long as 6-12 months and are known to be 100% patient compliant. However, despite being so effective and even affordable, internal bone growth stimulators face the downside of requiring double surgery – first for the implantation of the device and then for its removal. This not only incurs considerable costs, but also calls for additional healing time and energy due to two surgeries.
In contrast, external/non-invasive bone growth stimulators do not involve surgeries as these portable devices are meant to be worn externally. As there is no need for the surgical implantation of these devices, the overall cost of treatment is less than internal bone growth stimulators. Thus, despite being known to be less patient complaint, the demand for external/non-invasive bone growth stimulators has seen a significant rise in the past few years.
Browse Full Global Bone Growth Stimulators Market Report with TOC :http://www.mrrse.com/bone-growth-stimulators-market
North America Leads the Way for Global Bone Growth Stimulators Market
North America is presently the leading regional market for bone growth stimulators owing to the high prevalence of conditions such as osteoporosis and high consumer awareness regarding treatment modalities. High disposable incomes and high medical expenditures are also some reasons making North America the leading regional market for bone growth stimulators. The region, in combination with Europe, is projected to account for a massive 77.8% of the global market by the end of the forecast period.